1 minute read

Chapter 91: Lung Cancer Buttaro: Primary Care: A Collaborative Practice, 6th Edition

Multiple Choice

1. A patient with a cough has a suspicious lung lesion, a mediastinal lymph mass, and several bone lesions. What test is indicated to determine histology and staging of this cancer?

a. Biopsy of a bone lesion b. Bone marrow aspiration and biopsy c. Bronchoscopy with lung biopsy d. Thoracentesis and pleural fluid cytology

ANS: A a. Surgical resection will improve survival chances dramatically. b. That relapse is likely with a 2-year overall survival of 50%. c. There is an 80% chance of 5-year survival. d. Treatment will proceed with curative intent.

The diagnosis and stage should be determined in the least invasive manner possible. A single biopsy of the bone lesion can determine histology and staging. The other procedures are more invasive and not necessary.

2. A patient with limited stage small cell lung cancer (SCLC) has undergone chemotherapy with a good initial response to therapy. What will the provider tell this patient about the prognosis for treating this disease?

ANS: B

Although SCLC often responds very well initially to chemotherapy, the majority of patients will relapse and the 2-year survival rates are approximately 50%. Surgical resection does not play a significant role in the management of SCLC because the majority of patients have metastatic disease at diagnosis. Treatment is generally palliative.

Multiple Response

NURSINGTB.COM a. Reports of headache b. Increased presence of a cough c. Diagnostically confirmed low hematocrit d. Existence of lymph nodes greater than 1 cm e. Presence of unexplained weight gain greater than 10 pounds

1. When screening for metastatic cancer in a patient with lung cancer, what will the provider assess for? (Select all that apply.)

ANS: A, C, D

Headaches may indicate brain metastases. Low hematocrit and lymphadenopathy with nodes greater than 1 cm also indicate metastasis. Increased cough is a sign of lung cancer itself, not metastasis. Patients with metastatic cancer have unexplained weight loss of more than 10 pounds.

This article is from: